Julia Munoz-Sabin
Majadahonda, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation.
Journal: International journal of molecular sciences
Published: December 22, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Journal: Journal of clinical medicine
Published: September 15, 2023
The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study).
Journal: Journal of clinical medicine
Published: September 07, 2023
Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients.
Journal: Frontiers in immunology
Published: April 21, 2023
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 03, 2021
Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate.
Journal: Scientific reports
Published: November 18, 2021
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment.
Journal: Multiple sclerosis and related disorders
Published: December 30, 2020
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Journal: European journal of neurology
Published: December 21, 2020
High frequency of endoluminal thrombus in patients with ischaemic stroke following COVID-19
Journal: Neurologia
Published: September 06, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026